We narrowed to 25,818 results for: lars;

#195860

WT E. coli strain transformed with plasmid carrying WT chromogenic protein (CP). Serves as control for suppressor strains. Grows purple when CP is induced with rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#195859

WT E. coli strain transformed with plasmid carrying chromogenic protein (CP) with amber nonsense mutation in chromophore. Serves as control for suppressor strains. No color when grown with or without rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#195858

E. coli nonsense suppressor strain (leuX) transformed with plasmid carrying chromogenic protein (CP) with amber nonsense mutation in chromophore. Grows magenta when CP is induced with rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#195857

E. coli nonsense suppressor strain (tyrT) transformed with plasmid carrying chromogenic protein (CP) with amber nonsense mutation in chromophore. No color when grown with or without rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#195856

E. coli nonsense suppressor strain (serU) transformed with plasmid carrying chromogenic protein (CP) with amber nonsense mutation in chromophore. Grows salmon when CP is induced with rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#195855

E. coli nonsense suppressor strain (glnX) transformed with plasmid carrying chromogenic protein (CP) with amber nonsense mutation in chromophore. Grows purple when CP is induced with rhamnose.

Gregory Phillips

DeWolf et al J Microbiol Biol Educ. 2023 Oct 25;24(3)

Feb. 8, 2023

Academic Institutions and Nonprofits only

#192872

MG1655-C321 -- All 321 UAG codons changed to UAA

Jesse Rinehart

Gassaway et al Nat Methods. 2022 Oct 24. pii: 10.1038/s

Dec. 14, 2022

Academic Institutions and Nonprofits only

#42894

Bryan Berger

Su et al J Biol Chem. 2012 Jul 22.

March 28, 2013

Academic Institutions and Nonprofits only

#169942

Knockout library targeting ubiquitin ligases, deubiquitinases, and control genes.

Benjamin Ebert

Slabicki et al Nature. 2020 Sep;585(7824):293-297. doi:

Sept. 9, 2021

Academic Institutions and Nonprofits only

#51946

oriT-kan template

Farren Isaacs

Ma et al Nat Protoc. 2014 Oct;9(10):2285-300. doi

May 1, 2014

Academic Institutions and Nonprofits only

#228513

Indole-responsive Phage Infection Assay using LARP and T7 Phage with gp1 knock-out

Timothy Whitehead

Baumer et al ACS Synth Biol. 2024 Dec 20;13(12):4165-

Feb. 7, 2025

Academic Institutions and Nonprofits only

#196340

Bacterial strain lacking adenlyate cyclase (cyaA, needed for cAMP synthesis) and phosphodiesterase (cpdA, which degrades cAMP); unable to control its intracellular cAMP levels

Terence Hwa, Thomas Kuhlman

Kuhlman et al Proc Natl Acad Sci U S A. 2007 Apr 3;104

Nov. 12, 2025

Academic Institutions and Nonprofits only

#170511

Genome-wide knockout library. It is identical to the Brie library #73633, replacing Puromycin resistance with mCherry.

Pavel Tolar

Newman et al biorXiv 2021.03.02.433398

Sept. 9, 2021

Academic Institutions and Nonprofits only

#26966-AAV5

Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

Karl Deisseroth

Gradinaru et al Cell. 2010 Apr 2. 141(1):154-65.

Feb. 14, 2018

Academic Institutions and Nonprofits only

#26966-AAV9

Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

Karl Deisseroth

Gradinaru et al Cell. 2010 Apr 2. 141(1):154-65.

April 6, 2018

Academic Institutions and Nonprofits only

#26966-AAV1

Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

Karl Deisseroth

Gradinaru et al Cell. 2010 Apr 2. 141(1):154-65.

Feb. 14, 2018

Academic Institutions and Nonprofits only

#26966-AAVrg

Ready-to-use AAV Retrograde particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

Karl Deisseroth

Gradinaru et al Cell. 2010 Apr 2. 141(1):154-65.

March 27, 2024

Academic Institutions and Nonprofits only

#243682

For stable recombination of nearly all human GPCRs with unique molecular identifiers.

Jonathan Schlebach

Tedman et al bioRxiv 2025.09.19.677468

Oct. 27, 2025

Academic Institutions and Nonprofits only